Global Bio Pharma Logistics 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI02248293

Publication Date:

February 26, 2024

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bio Pharma Logistics market size was valued at US$ 69490 million in 2023. With growing demand in downstream market, the Bio Pharma Logistics is forecast to a readjusted size of US$ 98600 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global Bio Pharma Logistics market. Bio Pharma Logistics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Bio Pharma Logistics. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Bio Pharma Logistics market.
Logistics is a key component in the biopharmaceutical supply chain. In recent times, a dynamic business environment and a supply chain, which is outlined with greater complexity, have fueled the demand for a more precise and targeted approach to temperature control. Nations around the world are tightening their regulations to ensure secure and reliable transportation of pharmaceutical shipments.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Bio Pharma Logistics market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Bio Pharma Logistics market. It may include historical data, market segmentation by Type (e.g., Generic Drugs, Branded Drugs), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Bio Pharma Logistics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Bio Pharma Logistics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Bio Pharma Logistics industry. This include advancements in Bio Pharma Logistics technology, Bio Pharma Logistics new entrants, Bio Pharma Logistics new investment, and other innovations that are shaping the future of Bio Pharma Logistics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Bio Pharma Logistics market. It includes factors influencing customer ' purchasing decisions, preferences for Bio Pharma Logistics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Bio Pharma Logistics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Bio Pharma Logistics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Bio Pharma Logistics market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Bio Pharma Logistics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Bio Pharma Logistics market.
麻豆原创 Segmentation:
Bio Pharma Logistics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Generic Drugs
Branded Drugs
Segmentation by application
Air Shipping
Sea Shipping
Road Shipping
Rail Shipping
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
FedEx Corporation
Deutsche Post DHL Group
Panalpina World Transport
United Parcel Service
Ceva Logistics
Panalpina Group
Kuehne + Nagel International
DB Schenker
C.H. Robinson Worldwide
XPO Logistics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bio Pharma Logistics 麻豆原创 Size 2019-2030
2.1.2 Bio Pharma Logistics 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Bio Pharma Logistics Segment by Type
2.2.1 Generic Drugs
2.2.2 Branded Drugs
2.3 Bio Pharma Logistics 麻豆原创 Size by Type
2.3.1 Bio Pharma Logistics 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bio Pharma Logistics 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Bio Pharma Logistics Segment by Application
2.4.1 Air Shipping
2.4.2 Sea Shipping
2.4.3 Road Shipping
2.4.4 Rail Shipping
2.5 Bio Pharma Logistics 麻豆原创 Size by Application
2.5.1 Bio Pharma Logistics 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bio Pharma Logistics 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Bio Pharma Logistics 麻豆原创 Size by Player
3.1 Bio Pharma Logistics 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Bio Pharma Logistics Revenue by Players (2019-2024)
3.1.2 Global Bio Pharma Logistics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Bio Pharma Logistics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bio Pharma Logistics by Regions
4.1 Bio Pharma Logistics 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Bio Pharma Logistics 麻豆原创 Size Growth (2019-2024)
4.3 APAC Bio Pharma Logistics 麻豆原创 Size Growth (2019-2024)
4.4 Europe Bio Pharma Logistics 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Bio Pharma Logistics 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Bio Pharma Logistics 麻豆原创 Size by Country (2019-2024)
5.2 Americas Bio Pharma Logistics 麻豆原创 Size by Type (2019-2024)
5.3 Americas Bio Pharma Logistics 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio Pharma Logistics 麻豆原创 Size by Region (2019-2024)
6.2 APAC Bio Pharma Logistics 麻豆原创 Size by Type (2019-2024)
6.3 APAC Bio Pharma Logistics 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bio Pharma Logistics by Country (2019-2024)
7.2 Europe Bio Pharma Logistics 麻豆原创 Size by Type (2019-2024)
7.3 Europe Bio Pharma Logistics 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio Pharma Logistics by Region (2019-2024)
8.2 Middle East & Africa Bio Pharma Logistics 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Bio Pharma Logistics 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Bio Pharma Logistics 麻豆原创 Forecast
10.1 Global Bio Pharma Logistics Forecast by Regions (2025-2030)
10.1.1 Global Bio Pharma Logistics Forecast by Regions (2025-2030)
10.1.2 Americas Bio Pharma Logistics Forecast
10.1.3 APAC Bio Pharma Logistics Forecast
10.1.4 Europe Bio Pharma Logistics Forecast
10.1.5 Middle East & Africa Bio Pharma Logistics Forecast
10.2 Americas Bio Pharma Logistics Forecast by Country (2025-2030)
10.2.1 United States Bio Pharma Logistics 麻豆原创 Forecast
10.2.2 Canada Bio Pharma Logistics 麻豆原创 Forecast
10.2.3 Mexico Bio Pharma Logistics 麻豆原创 Forecast
10.2.4 Brazil Bio Pharma Logistics 麻豆原创 Forecast
10.3 APAC Bio Pharma Logistics Forecast by Region (2025-2030)
10.3.1 China Bio Pharma Logistics 麻豆原创 Forecast
10.3.2 Japan Bio Pharma Logistics 麻豆原创 Forecast
10.3.3 Korea Bio Pharma Logistics 麻豆原创 Forecast
10.3.4 Southeast Asia Bio Pharma Logistics 麻豆原创 Forecast
10.3.5 India Bio Pharma Logistics 麻豆原创 Forecast
10.3.6 Australia Bio Pharma Logistics 麻豆原创 Forecast
10.4 Europe Bio Pharma Logistics Forecast by Country (2025-2030)
10.4.1 Germany Bio Pharma Logistics 麻豆原创 Forecast
10.4.2 France Bio Pharma Logistics 麻豆原创 Forecast
10.4.3 UK Bio Pharma Logistics 麻豆原创 Forecast
10.4.4 Italy Bio Pharma Logistics 麻豆原创 Forecast
10.4.5 Russia Bio Pharma Logistics 麻豆原创 Forecast
10.5 Middle East & Africa Bio Pharma Logistics Forecast by Region (2025-2030)
10.5.1 Egypt Bio Pharma Logistics 麻豆原创 Forecast
10.5.2 South Africa Bio Pharma Logistics 麻豆原创 Forecast
10.5.3 Israel Bio Pharma Logistics 麻豆原创 Forecast
10.5.4 Turkey Bio Pharma Logistics 麻豆原创 Forecast
10.5.5 GCC Countries Bio Pharma Logistics 麻豆原创 Forecast
10.6 Global Bio Pharma Logistics Forecast by Type (2025-2030)
10.7 Global Bio Pharma Logistics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 FedEx Corporation
11.1.1 FedEx Corporation Company Information
11.1.2 FedEx Corporation Bio Pharma Logistics Product Offered
11.1.3 FedEx Corporation Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 FedEx Corporation Main Business Overview
11.1.5 FedEx Corporation Latest Developments
11.2 Deutsche Post DHL Group
11.2.1 Deutsche Post DHL Group Company Information
11.2.2 Deutsche Post DHL Group Bio Pharma Logistics Product Offered
11.2.3 Deutsche Post DHL Group Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Deutsche Post DHL Group Main Business Overview
11.2.5 Deutsche Post DHL Group Latest Developments
11.3 Panalpina World Transport
11.3.1 Panalpina World Transport Company Information
11.3.2 Panalpina World Transport Bio Pharma Logistics Product Offered
11.3.3 Panalpina World Transport Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Panalpina World Transport Main Business Overview
11.3.5 Panalpina World Transport Latest Developments
11.4 United Parcel Service
11.4.1 United Parcel Service Company Information
11.4.2 United Parcel Service Bio Pharma Logistics Product Offered
11.4.3 United Parcel Service Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 United Parcel Service Main Business Overview
11.4.5 United Parcel Service Latest Developments
11.5 Ceva Logistics
11.5.1 Ceva Logistics Company Information
11.5.2 Ceva Logistics Bio Pharma Logistics Product Offered
11.5.3 Ceva Logistics Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Ceva Logistics Main Business Overview
11.5.5 Ceva Logistics Latest Developments
11.6 Panalpina Group
11.6.1 Panalpina Group Company Information
11.6.2 Panalpina Group Bio Pharma Logistics Product Offered
11.6.3 Panalpina Group Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Panalpina Group Main Business Overview
11.6.5 Panalpina Group Latest Developments
11.7 Kuehne + Nagel International
11.7.1 Kuehne + Nagel International Company Information
11.7.2 Kuehne + Nagel International Bio Pharma Logistics Product Offered
11.7.3 Kuehne + Nagel International Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Kuehne + Nagel International Main Business Overview
11.7.5 Kuehne + Nagel International Latest Developments
11.8 DB Schenker
11.8.1 DB Schenker Company Information
11.8.2 DB Schenker Bio Pharma Logistics Product Offered
11.8.3 DB Schenker Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 DB Schenker Main Business Overview
11.8.5 DB Schenker Latest Developments
11.9 C.H. Robinson Worldwide
11.9.1 C.H. Robinson Worldwide Company Information
11.9.2 C.H. Robinson Worldwide Bio Pharma Logistics Product Offered
11.9.3 C.H. Robinson Worldwide Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 C.H. Robinson Worldwide Main Business Overview
11.9.5 C.H. Robinson Worldwide Latest Developments
11.10 XPO Logistics
11.10.1 XPO Logistics Company Information
11.10.2 XPO Logistics Bio Pharma Logistics Product Offered
11.10.3 XPO Logistics Bio Pharma Logistics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 XPO Logistics Main Business Overview
11.10.5 XPO Logistics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.